Posterior reversible encephalopathy associated with pembrolizumab

Neurologia (Engl Ed). 2021 Sep;36(7):548-550. doi: 10.1016/j.nrleng.2020.08.014. Epub 2021 Jun 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Brain Diseases*
  • Humans
  • Posterior Leukoencephalopathy Syndrome* / chemically induced

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab